A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
about
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.Biomarkers and therapeutic advances in glioblastoma multiforme.Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.
P2860
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@en
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@nl
type
label
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@en
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@nl
prefLabel
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@en
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
@en
P2093
Adriana Pitea
Carsten Sticht
Claus Belka
Daniel Piehlmaier
Franz Zehentmayr
Horst Zitzelsberger
Joachim Steinbach
Kirsten Lauber
Kristian Unger
Maximilian Niyazi
P2860
P304
45764-45775
P356
10.18632/ONCOTARGET.9945
P407
P577
2016-06-11T00:00:00Z